Physician profile
Seema P Kumar
NPI 1891759429
$496.65
in general payments reported to CMS, 2019-2025
10 companies · $38.07 in 2025
The $38.07 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.85 · 2020: $26.86 · 2021: $102 · 2022: $86.31 · 2023: $158 · 2024: $18.42 · 2025: $38.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $103.02 | 2019-2021 | |
| Nevro Corp. | $95.17 | 2022-2023 | Senza |
| Janssen Pharmaceuticals, INC | $81.87 | 2022-2023 | Xarelto |
| Boston Scientific Corporation | $52.42 | 2021-2022 | |
| Cashflow Solutions, LLC | $50.28 | 2022-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Takeda Pharmaceuticals U.S.A., INC. | $38.07 | 2025 | Eohilia |
| Organogenesis INC. | $31.05 | 2021 | |
| Biocompatibles, INC. | $15.89 | 2019 | |
| Sunovion Pharmaceuticals INC. | $14.54 | 2021 | |
| Medtronic Vascular, INC. | $14.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seema Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.